EUVIMEDEUVIMED entdecken
Open Access

The Real-World Impact of Vitamin D Supplementation on Inflammatory Bowel Disease Clinical Outcomes

Jared A Sninsky, Shubhada Sansgiry, Thomas Taylor, Michael Perrin, Fasiha Kanwal, Jason K Hou

Clinical Gastroenterology and Hepatology · 2026-06 · 24 (6) · 1666-1674.e2

DOI: 10.1016/j.cgh.2025.07.013 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Gastroenterology and Hepatology, 2026-06. Verfasst von Jared A Sninsky und 5 weiteren Autor:innen. Beteiligte Einrichtung: VA Center for Innovations in Quality, Effectiveness, and Safety (IQuESt), Michael E. DeBakey VA Medical Center, Houston, Texas; Division of Gastroent…. Hauptthemen laut MEDLINE: Vitamin D, Dietary Supplements, Inflammatory Bowel Diseases, Vitamin D Deficiency. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: HSRD VA, NCATS NIH HHS, Department of Veterans Affairs.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND & AIMS: Vitamin D deficiency is common in inflammatory bowel disease (IBD) and linked to adverse outcomes, yet the therapeutic role of vitamin D supplementation remains uncertain. We evaluated the real-world impact of vitamin D supplementation on corticosteroid use, emergency department visits, and hospitalizations in patients with IBD. METHODS: We conducted a retrospective cohort study of patients with IBD seen in the national Veterans Health Administration system from 2000 to 2023. All patients who had a vitamin D laboratory assay without a vitamin D prescription in the preceding 3 months were included. We used the quasi-experimental design with difference-in-differences analysis to compare vitamin D-treated and untreated groups before and after the 25-hydroxyvitamin D assay. Sensitivity analyses used regression discontinuity design and inverse probability weighting regression to confirm results from the primary analysis. RESULTS: Among 5021 patients with IBD (median age, 63; 89% male; 58% ulcerative colitis, 39% Crohn's disease, 3% indeterminate colitis), the median 25-hydroxyvitamin D level was 23 ng/mL, and 41% received vitamin D supplementation. Vitamin D supplementation was associated with reduction in IBD-related emergency department visits by 2.17% (34.4% relative risk reduction; P = .007), hospitalizations by 2.64% (53.18% relative risk reduction; P = .003), and corticosteroid prescriptions by 1.29% (25.13% relative risk reduction; P = .066). Similar results were seen in the inverse probability weighted regression and regression discontinuity design analyses. CONCLUSIONS: Vitamin D supplementation was associated with reduced IBD-related emergency department visits, hospitalizations, and corticosteroid use, supporting its potential as a low-cost adjunct in IBD management. Prospective studies are needed to optimize dosing strategies and define target serum levels for improved long-term outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Vitamin DDietary SupplementsInflammatory Bowel DiseasesVitamin D DeficiencyVitaminsHumansMaleFemaleRetrospective StudiesMiddle AgedAgedHospitalizationEmergency Service, HospitalAdrenal Cortex HormonesUnited StatesAdult

Stichwörter der Autor:innen

25-Hydroxyvitamin DInflammatory Bowel DiseaseQuasi-experimentalVitamin D

Substanzen

Vitamin DAdrenal Cortex Hormones25-hydroxyvitamin DVitamins

Autor:innen und Institutionen

  • VA Center for Innovations in Quality, Effectiveness, and Safety (IQuESt), Michael E. DeBakey VA Medical Center, Houston, Texas; Division of Gastroenterology and Hepatology, Department of Medicine, Baylor College of Medi…
  • VA Center for Innovations in Quality, Effectiveness, and Safety (IQuESt), Michael E. DeBakey VA Medical Center, Houston, Texas; Michael E. DeBakey VA Medical Center, VA South Central MIRECC, Houston, Texas; Division of…
  • Division of Gastroenterology and Hepatology, Department of Medicine, Baylor College of Medicine, Houston, Texas.
  • Michael E. DeBakey VA Medical Center, VA South Central MIRECC, Houston, Texas.

Förderung

  • HSRD VA
  • NCATS NIH HHS
  • Department of Veterans Affairs
  • PCORI
  • NIH

Zitieren

APA

Sninsky, J. A., Sansgiry, S., Taylor, T., Perrin, M., Kanwal, F., & Hou, J. K. (2026). The Real-World Impact of Vitamin D Supplementation on Inflammatory Bowel Disease Clinical Outcomes. Clinical Gastroenterology and Hepatology, 24(6), 1666-1674.e2. https://doi.org/10.1016/j.cgh.2025.07.013

Vancouver

Sninsky JA, Sansgiry S, Taylor T, Perrin M, Kanwal F, Hou JK. The Real-World Impact of Vitamin D Supplementation on Inflammatory Bowel Disease Clinical Outcomes. Clinical Gastroenterology and Hepatology. 2026;24(6):1666-1674.e2. doi:10.1016/j.cgh.2025.07.013

BibTeX
@article{Sninsky2026,
  author = {Sninsky, Jared A and Sansgiry, Shubhada and Taylor, Thomas and Perrin, Michael and Kanwal, Fasiha and Hou, Jason K},
  title = {The Real-World Impact of Vitamin D Supplementation on Inflammatory Bowel Disease Clinical Outcomes},
  journal = {Clinical Gastroenterology and Hepatology},
  year = {2026},
  volume = {24},
  number = {6},
  pages = {1666--1674.e2},
  doi = {10.1016/j.cgh.2025.07.013}
}
Kostenlos starten →